首页> 美国卫生研究院文献>The Canadian Journal of Cardiology >Endothelial progenitor cell-seeded grafts: Rash and risky
【2h】

Endothelial progenitor cell-seeded grafts: Rash and risky

机译:内皮祖细胞接种的移植物:皮疹和危险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The patency of prosthetic vascular grafts is impaired by intimal hyperplasia (IH) near the anastomotic regions. The absence of a functional endothelial monolayer on the prosthetic grafts is an important stimulus for IH. To improve the outcome of synthetic vascular bypass surgery, cell seeding is a promising concept that has been extensively investigated and is still evolving. In the present paper, the concept of prosthetic graft cell seeding is discussed, with emphasis on its newest era: seeding with endothelial progenitor cells. Although experimental studies on prosthetic graft seeding using endothelial progenitor cells have shown excellent results on graft endothelialization, none of these studies reported favourable effects on the more clinically relevant end points such as IH or graft patency.
机译:吻合口附近的内膜增生(IH)会损害人造血管移植物的通畅性。人工移植物上缺少功能性内皮单层是IH的重要刺激因素。为了改善人工血管搭桥手术的效果,细胞播种是一个有前途的概念,已被广泛研究并且仍在发展中。在本文中,讨论了假体移植细胞播种的概念,重点是其最新时代:内皮祖细胞播种。尽管使用内皮祖细胞进行人工移植物植入的实验研究显示了移植物内皮化的优异结果,但这些研究均未报道对临床上更相关的终点(例如IH或移植物通畅)具有有利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号